Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I–type II study from the GINECO group
Heudel, P-E, Fabbro, M, Roemer-Becuwe, C, Kaminsky, M C, Arnaud, A, Joly, F, Roche-Forestier, S, Meunier, J, Foa, C, You, B, Priou, F, Tazi, Y, Floquet, A, Selle, F, Berton-Rigaud, D, Lesoin, A, Kalbacher, E, Lortholary, A, Favier, L, Treilleux, I, Ray-Coquard, I
Published in British journal of cancer (01.01.2017)
Published in British journal of cancer (01.01.2017)
Get full text
Journal Article
Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial
Fléchon, A., Pouessel, D., Ferlay, C., Perol, D., Beuzeboc, P., Gravis, G., Joly, F., Oudard, S., Deplanque, G., Zanetta, S., Fargeot, P., Priou, F., Droz, J.P., Culine, S.
Published in Annals of oncology (01.11.2011)
Published in Annals of oncology (01.11.2011)
Get full text
Journal Article
Updated results of GETUG-12, a phase III trial of docetaxel-based chemotherapy in high-risk localized prostate cancer, with a 12-year follow-up
Fizazi, K., Carmel, A., Joly, F., Delva, R., Gravis, G., Rolland, F., Priou, F., Ferrero, J.-M., Houede, N., Mourey, L., Theodore, C., Krakowski, I., Berdah, J.-F., Baciuchka Palmaro, M., Laguerre, B., Flechon, A., Ravaud, A., Brihoum, M., Culine, S., Le Teuff, G.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1874 Phase 1b/2 study results for masitinib plus gemcitabine and carboplatin in advanced triple negative breast cancer
Campone, M, Ferrero, J.M, Gunzer, K, Priou, F, Dubreuil, P, Mansfield, C, Moussy, A, Hermine, O
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
2621 Everolimus in advanced urothelial carcinoma (UC) pretreated with at least 2 lines of chemotherapy (CT) the afinivest study
Theodore, C, Gravisd-Mescam, G, Meunier, J, Guillot, A, Voog, E, Aubert, D, Priou, F
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: Results of the randomised GEFCAPI 02 trial
Gross-Goupil, M, Fourcade, A, Blot, E, Penel, N, Négrier, S, Culine, S, Chaigneau, L, Lesimple, T, Priou, F, Lortholary, A, Kaminsky, M.C, Provencal, J, Voog, E, Bouzy, J, Laplanche, A, Fizazi, K
Published in European journal of cancer (1990) (01.03.2012)
Published in European journal of cancer (1990) (01.03.2012)
Get full text
Journal Article
A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil–epirubicine–cyclophosphamide (FEC100 ) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000)
Delbaldo, C, Serin, D, Mousseau, M, Greget, S, Audhuy, B, Priou, F, Berdah, J.F, Teissier, E, Laplaige, P, Zelek, L, Quinaux, E, Buyse, M, Piedbois, P
Published in European journal of cancer (1990) (01.01.2014)
Published in European journal of cancer (1990) (01.01.2014)
Get full text
Journal Article
Long-term follow-up of HER2-overexpressing stage II or III breast cancer treated by anthracycline-free neoadjuvant chemotherapy
Guiu, S., Liegard, M., Favier, L., van Praagh, I., Largillier, R., Weber, B., Coeffic, D., Moreau, L., Priou, F., Campone, M., Gligorov, J., Vanlemmens, L., Trillet-Lenoir, V., Arnould, L., Coudert, B.
Published in Annals of oncology (01.02.2011)
Published in Annals of oncology (01.02.2011)
Get full text
Journal Article
Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer
Eymard, J-C, Priou, F, Zannetti, A, Ravaud, A, Lepillé, D, Kerbrat, P, Gomez, P, Paule, B, Genet, D, Hérait, P, Ecstein-Fraïssé, E, Joly, F
Published in Annals of oncology (01.06.2007)
Published in Annals of oncology (01.06.2007)
Get full text
Journal Article
Dose-dense adjuvant chemotherapy in node-positive breast cancer: docetaxel followed by epirubicin/cyclophosphamide (T/EC), or the reverse sequence (EC/T), every 2 weeks, versus docetaxel, epirubicin and cyclophosphamide (TEC) every 3 weeks. AERO B03 randomized phase II study
Piedbois, P., Serin, D., Priou, F., Laplaige, P., Greget, S., Angellier, E., Teissier, E., Berdah, J.-F., Fabbro, M., Valenza, B., Herait, P., Jehl, V., Buyse, M.
Published in Annals of oncology (01.01.2007)
Published in Annals of oncology (01.01.2007)
Get full text
Journal Article
Agreement for depression diagnosis between DSM-IV-TR criteria, three validated scales, oncologist assessment, and psychiatric clinical interview in elderly patients with advanced ovarian cancer
Rhondali, Wadih, Freyer, Gilles, Adam, Virginie, Filbet, Marilène, Derzelle, Martine, Abgrall-Barbry, Gaelle, Bourcelot, Sophie, Machavoine, Jean-Louis, Chomat-Neyraud, Muriel, Gisserot, Olivier, Largillier, Rémi, Le Rol, Annick, Priou, Frank, Saltel, Pierre, Falandry, Claire
Published in Clinical interventions in aging (01.01.2015)
Published in Clinical interventions in aging (01.01.2015)
Get full text
Journal Article
Carcinoma of an unknown primary: are EGF receptor, Her-2 neu, and c-Kit tyrosine kinases potential targets for therapy?
MASSARD, C, VOIGT, J.-J, PIVOT, X, COUDERT, B, DOUILLARD, J.-Y, MERROUCHE, Y, FIZAZI, K, LAPLANCHE, A, CULINE, S, LORTHOLARY, A, BUGAT, R, THEODORE, C, PRIOU, F, KAMINSKY, M.-C, LESIMPLE, T
Published in British journal of cancer (08.10.2007)
Published in British journal of cancer (08.10.2007)
Get full text
Journal Article
Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers
Escudier, B, Droz, J P, Rolland, F, Terrier-Lacombe, M J, Gravis, G, Beuzeboc, P, Chauvet, B, Chevreau, C, Eymard, J C, Lesimple, T, Merrouche, Y, Oudard, S, Priou, F, Guillemare, C, Gourgou, S, Culine, S
Published in The Journal of urology (01.09.2002)
Published in The Journal of urology (01.09.2002)
Get more information
Journal Article
A phase II study of oral uracil ftorafur (UFT ) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer
BENNOUNA, J, PERRIER, H, MALEK, K, TONELLI, D, DOUILLARD, J. Y, PAILLOT, B, PRIOU, F, JACOB, J. H, HEBBAR, M, BORDENAVE, S, SEITZ, J. F, CVITKOVIC, F, DORVAL, E
Published in British journal of cancer (16.01.2006)
Published in British journal of cancer (16.01.2006)
Get full text
Journal Article
Reply to Letter to the editor, by Ishiguro et al. (Ann Oncol)
Piedbois, P., Serin, D., Priou, F., Laplaige, P., Berdah, J.-F., Grenier, J.
Published in Annals of oncology (01.05.2008)
Published in Annals of oncology (01.05.2008)
Get full text
Journal Article
Is docetaxel-prednisone (DP) feasible in frail elderly (75 +) patient with castration-resistant metastatic prostate cancer (CRMPC)? A prospective randomized study after geriatric assessment from gerico and getug unicancer groups
Mourey, L, Gravis-Mescam, G, Sevin, E, Priou, F, Bompas, E, Sarda, C, Houede, N, Carola, E, Abadie, S, Latorzeff, I, Orsini, C, Filleron, T
Published in Journal of geriatric oncology (01.10.2013)
Published in Journal of geriatric oncology (01.10.2013)
Get full text
Journal Article
Carcinoma of an unknown primary: are EGF receptor, Her-2 neu, and c-Kit tyrosine kinases potential targets for therapy?
Massard, C, Voigt, J-j, Laplanche, A, Culine, S, Lortholary, A, Bugat, R, Theodore, C, Priou, F, Kaminsky, M-c, Lesimple, T, Pivot, X, Coudert, B, Douillard, J-y, Merrouche, Y, Fizazi, K
Published in British journal of cancer (02.12.2008)
Published in British journal of cancer (02.12.2008)
Get full text
Journal Article
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
Miles, D., Gligorov, J., Cameron, D., Xu, B., Semiglazov, V., Reinisch, M., Patre, M., Morales, L., Patel, S.L., Barata, T., Xu, B., Shao, Z., Wang, X., Geng, C., Yan, X., Tong, Z., Sun, T., Yang, J., Liu, Q., Zhang, S., De Laurentiis, M., Santoro, A., Colleoni, M., Cortesi, L., Placido, S., Ferrau, F., Del Mastro, L., Tonini, G., Montemurro, F., Bianchi, G., Prete, S., Allegrini, G., Naso, G., Vici, P., Loirat, D., Tredan, O., Gligorov, J., Timar David, M., Dohollou, N., Spano, J.-P., Mansi, L., Andrade, L., Damian, F., Aleixo, S., Junior, R., Reinisch, M., Grischke, E.-M., Harbeck, N., Peters, U., Fischer, D., Forstbauer, H., Warner, E., Bouganim, N., Vandenberg, T., Pavic, M., Robinson, A., Califaretti, N., Alacacioglu, A., Gumus, M., Yalcin, B., Cicin, I., Kose, F., Cubukcu, E., Wardley, A., Miles, D., Gupta, S., Mohapatra, P., Ghadyalpatil, N., Singhal, M., Agarwal, A., Wolf, I., Gal Yam, E., Yerushalmi, R., Peretz, T., Ben Baruch, N., Hamilton, E., Brufsky, A., Wright, G., Graff, S., Semiglazov, V., Ruiz Borrego, M., Merino, L., Guerra Martinez, J., Ohtani, S., Inoue, K., Ito, Y., Niikura, N., Sagara, Y., Yanagita, Y., Kaen, D., Nervo, A., Melichar, B., Sormova, P., Sufliarsky, J., Kakalejcik, M., Belbaraka, R., Errihani, H., Le Than, D., Pham, D., Papandreou, C.
Published in Annals of oncology (01.08.2021)
Published in Annals of oncology (01.08.2021)
Get full text
Journal Article
1627P Long survivors after androgen deprivation therapy (ADT) with or without docetaxel for metastatic castration-sensitive prostate cancer (mCSPC): Long-term follow-up of GETUG-15
Blanchet-Deverly, S., Fizazi, K., Oudard, S., Gravis, G., Boughalem, E., Borchiellini, D., Foulon, S., Peyre Pradat, F., Beuzeboc, P., Mourey, L., Laguerre, B., Jacobs, M., Tosi, D., Priou, F., Sfumato, P., Massard, V.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
773P Role of tumor primary chemosensitivity assessed by modeled CA-125 KELIM to predict complete interval debulking surgery (IDS) in ovarian carcinoma patients treated with neo-adjuvant chemotherapy and immunotherapy: A GINEGEPS/GINECO study of the NeoPembrOv and INeOV trials
Corbaux, P., Leary, A., Le Saux, O., Colomban, O., Treilleux, I., Genestie, C., Chardin, L., Collet, L., Bengrine Lefevre, L., Auvray Kuentz, M., Martinez, M., Blonz, C., Priou, F., Alexandre, J., Cloarec, N., Lebreton, C., Venat, L., Savoye, A.M., You, B., Ray-Coquard, I.L.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article